Allen L Feng1, Yun-Yan Xiang1, Le Gui2, Gesthika Kaltsidis2, Qingping Feng2, Wei-Yang Lu3,4. 1. Robarts Research Institute, Rome: 7240, University of Western Ontario, 1151 Richmond Street North, London, ON, N6A 5B7, Canada. 2. Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada. 3. Robarts Research Institute, Rome: 7240, University of Western Ontario, 1151 Richmond Street North, London, ON, N6A 5B7, Canada. wlu53@uwo.ca. 4. Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada. wlu53@uwo.ca.
Abstract
AIMS/HYPOTHESIS: This study aimed to elucidate the mechanism of increased proliferation of alpha cells in recent-onset type 1 diabetes. Pancreatic beta cells express GAD and produce γ-aminobutyric acid (GABA), which inhibits alpha cell secretion of glucagon. We explored the roles of GABA in alpha cell proliferation in conditions corresponding to type 1 diabetes in a mouse model and in vitro. METHODS: Type 1 diabetes was induced by injecting the mice with streptozotocin (STZ). Some of the STZ-injected mice were treated with GABA (10 mg/kg daily) for 12 days. Isolated pancreatic islets were treated with STZ or STZ together with GABA for 2 days. The effects of GABA treatment on STZ-induced alpha cell proliferation in vivo and in vitro were assessed. The effect of muscimol, a GABA receptor agonist, on αTC1-6 cell proliferation was also examined. RESULTS: STZ injection substantially decreased levels of GAD, GABA and insulin in pancreatic beta cells 12 h after injection; this was followed by an upsurge of phosphorylated mechanistic target of rapamycin (p-mTOR) in the alpha cells at day 1, and a significant increase in alpha cell mass at day 3. Treating STZ-injected mice with GABA largely restored the immunodetectable levels of insulin and GAD in the beta cells and significantly decreased the number of aldehyde dehydrogenase 1 family, member A3 (ALDH1a3)-positive cells, alpha cell mass and hyperglucagonaemia. STZ treatment also increased alpha cell proliferation in isolated islets, which was reversed by co-treatment with GABA. Muscimol, together with insulin, significantly lowered the level of cytosolic Ca2+ and p-mTOR, and decreased the proliferation rate of αTC1-6 cells. CONCLUSIONS/ INTERPRETATION: GABA signalling critically controls the alpha cell population in pancreatic islets. Low intraislet GABA may contribute to alpha cell hyperplasia in early type 1 diabetes.
AIMS/HYPOTHESIS: This study aimed to elucidate the mechanism of increased proliferation of alpha cells in recent-onset type 1 diabetes. Pancreatic beta cells express GAD and produce γ-aminobutyric acid (GABA), which inhibits alpha cell secretion of glucagon. We explored the roles of GABA in alpha cell proliferation in conditions corresponding to type 1 diabetes in a mouse model and in vitro. METHODS:Type 1 diabetes was induced by injecting the mice with streptozotocin (STZ). Some of the STZ-injected mice were treated with GABA (10 mg/kg daily) for 12 days. Isolated pancreatic islets were treated with STZ or STZ together with GABA for 2 days. The effects of GABA treatment on STZ-induced alpha cell proliferation in vivo and in vitro were assessed. The effect of muscimol, a GABA receptor agonist, on αTC1-6 cell proliferation was also examined. RESULTS:STZ injection substantially decreased levels of GAD, GABA and insulin in pancreatic beta cells 12 h after injection; this was followed by an upsurge of phosphorylated mechanistic target of rapamycin (p-mTOR) in the alpha cells at day 1, and a significant increase in alpha cell mass at day 3. Treating STZ-injected mice with GABA largely restored the immunodetectable levels of insulin and GAD in the beta cells and significantly decreased the number of aldehyde dehydrogenase 1 family, member A3 (ALDH1a3)-positive cells, alpha cell mass and hyperglucagonaemia. STZ treatment also increased alpha cell proliferation in isolated islets, which was reversed by co-treatment with GABA. Muscimol, together with insulin, significantly lowered the level of cytosolic Ca2+ and p-mTOR, and decreased the proliferation rate of αTC1-6 cells. CONCLUSIONS/ INTERPRETATION:GABA signalling critically controls the alpha cell population in pancreatic islets. Low intraislet GABA may contribute to alpha cell hyperplasia in early type 1 diabetes.
Authors: Matthias Braun; Reshma Ramracheya; Martin Bengtsson; Anne Clark; Jonathan N Walker; Paul R Johnson; Patrik Rorsman Journal: Diabetes Date: 2010-04-22 Impact factor: 9.461
Authors: Alexandra Alvarsson; Maria Jimenez-Gonzalez; Rosemary Li; Carolina Rosselot; Nikolaos Tzavaras; Zhuhao Wu; Andrew F Stewart; Adolfo Garcia-Ocaña; Sarah A Stanley Journal: Sci Adv Date: 2020-10-09 Impact factor: 14.136
Authors: Danusa Menegaz; D Walker Hagan; Joana Almaça; Chiara Cianciaruso; Rayner Rodriguez-Diaz; Judith Molina; Robert M Dolan; Matthew W Becker; Petra C Schwalie; Rita Nano; Fanny Lebreton; Chen Kang; Rajan Sah; Herbert Y Gaisano; Per-Olof Berggren; Steinunn Baekkeskov; Alejandro Caicedo; Edward A Phelps Journal: Nat Metab Date: 2019-11-15
Authors: Artem V Artiukhov; Aneta Grabarska; Ewelina Gumbarewicz; Vasily A Aleshin; Thilo Kähne; Toshihiro Obata; Alexey V Kazantsev; Nikolay V Lukashev; Andrzej Stepulak; Alisdair R Fernie; Victoria I Bunik Journal: Sci Rep Date: 2020-02-05 Impact factor: 4.379